Page URL: https://www.bionews.org.uk/page_94217

HFEA will remain independent, says UK Government

22 July 2013
Appeared in BioNews 714

The Department of Health has announced that the Human Fertilisation and Embryology Authority (HFEA) will remain the independent regulator of assisted reproduction and embryo research in the UK. The decision follows an independent review of the HFEA and the Human Tissue Authority (HTA), the regulator for human tissue research.

In 2010 the Government's plans to transfer functions from the HFEA and the HTA to the Care Quality Commission (CQC) and the Health Research Agency (HRA) were made public (see BioNews 577). However, after a public consultation (see BioNews 690) dissuaded the government from this course of action, it then considered merging the HFEA with the HTA to reduce expenditure and bureaucracy and to simplify regulation.

The independent review of the two bodies, carried out by Justin McCracken, the former chief executive of the now-dissolved Health Protection Agency, contained 18 recommendations, 13 of which were relevant to the HFEA. It found that there was little practical overlap in their work with that of the HTA.

The recommendations included the need to maintain public confidence in the activities that the HFEA and HTA regulate, and while both organisations enjoy that trust at the moment, merging them could risk losing it. The HFEA issued a short statement saying that 'many of [the proposed changes] are already underway'.

The report further suggested that to improve transparency, both organisations needed to improve their consultations with stakeholders when carrying out their regulatory activities. Other recommendations included the need for the HFEA to rebalance its activities somewhat, for example by ensuring that appropriate standards of practice are implemented consistently throughout the sector. The HFEA was reminded that it should implement its agreement with the CQC, to ensure that the two bodies do not duplicate regulatory work.

Although the organisations will retain their distinct identities, the report suggested that the support services could be combined and managed by a single director of finance and resources, which would save an estimated £2.8 million over ten years.

The Department of Health has accepted all the recommendations and will consider the support services suggestion. It has already held preliminary discussions with the HFEA and HTA about the recommendations.

The Parliamentary Under-Secretary of State for public health, Anna Soubry, said in a written statement: 'We believe that implementation will bring about increased efficiency and effectiveness of the regulators whilst maintaining public and professional confidence in these sensitive and complex areas'.

SOURCES & REFERENCES
HFEA to remain as independent regulator of assisted reproduction
Human Fertilisation and Embryology Authority (press release) |  17 July 2013
Review of Human Fertilisation & Embryology Authority and Human Tissue Authority
UK Government - Department of Health |  17 July 2013
UK medical research regulators spared the axe
Nature News |  18 July 2013
U.K. Won't Eliminate Embryo Research Authority
ScienceInsider |  18 July 2013
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
24 April 2017 - by Antony Starza-Allen 
A claim for judicial review that sought to challenge changes to the way the Human Fertilisation and Embryology Authority (HFEA) presents data about UK fertility clinics on its website has failed...
20 October 2014 - by Stephen Harbottle 
The Association of Clinical Embryologists is concerned that proposals to devolve powers for forming legislation covering the provision of fertility treatment, genetic screening and abortion to the Scottish Parliament may be a step too far in the process of devolution...
3 March 2014 - by Peter Thompson 
IVF in the UK is thriving. But is it as good as it could be? We at the HFEA want to think about how we can get the best out of the IVF sector in the UK...
16 December 2013 - by Antony Starza-Allen 
The Human Fertilisation and Embryology Authority has announced the appointment of Sally Cheshire as its interim chair when Professor Lisa Jardine's term as chair comes to an end in January 2014....
15 November 2013 - by Antony Starza-Allen 
The UK's High Court has ruled against the Human Fertilisation and Embryology Authority saying its actions towards two clinics over a licence condition to impose a maximum multiple birth rate were unlawful. The HFEA has now decided to withdraw the condition from all UK fertility clinics' licences...
3 June 2013 - by Professor Alison Murdoch 
The culture of the Human Fertilisation and Embryology Authority is now one based on self-aggrandisement and self-preservation. But cultural problems with fertility treatment in England and Wales do not stop there and other stakeholders must also be called to account...
7 May 2013 - by Natalie Gamble 
The Human Fertilisation and Embryology Authority (HFEA) voted on 20 March 2013 to update the guidance it gives to UK fertility clinics on surrogacy. It is a welcome decision that will mean better support for the growing numbers of families created through surrogacy in the UK....
28 January 2013 - by Baroness Ruth Deech 
In January the Department of Health published its response to the consultation on proposals to transfer the functions of the Human Fertilisation and Embryology Authority and the Human Tissue Authority to the Care Quality Commission and the new Health Research Authority...
28 January 2013 - by Dr Louisa Petchey 
The Human Fertilisation and Embryology Authority (HFEA) and Human Tissue Authority (HTA) have been spared the 'bonfire of the quangos' it was announced on Friday, but will be subject to an independent review to improve efficiency...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.